Noninvasive prenatal testing in routine clinical practice for a high-risk population Experience from a center

Medicine (United States)

Volumn 95, Issue 41, 2016, Pages

  Qi, Guijie ^a,b   Yi, Jianping ^b   Han, Baosheng ^b   Liu, Heng ^b   Guo, Wanru ^b   Shi, Chong ^b   Yin, Lirong ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Department of Gynecology and Obstetrics Tangshan Maternal and Children Health Hospital   (China)

Author keywords

chromosomal abnormalities; maternal serum screening; noninvasive prenatal testing; ultrasound screening

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; NON INVASIVE PROCEDURE; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TRISOMY 13; TRISOMY 18; TRISOMY 21; FETAL DISEASES; GENETIC SCREENING; GENETICS; GESTATIONAL AGE; PREGNANCY; PROCEDURES; RISK FACTOR;

ADULT; ANEUPLOIDY; FEMALE; FETAL DISEASES; FOLLOW-UP STUDIES; GENETIC TESTING; GESTATIONAL AGE; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85012009999     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000005126     Document Type: Article

References (34)

1. Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: Updated metaanalysis. Ultrasound Obstet Gynecol 2015; 45:249-66.
2. Benn P, Cuckle H, Pergament E. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012; 119: 1270-1.
3. Norton ME, Brar H, Weiss J, et al. Non-Invasive Chromosomal Evaluation (NICE) study: Results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 207:131-8.
4. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: An international collaborative study. Genet Med 2012; 14: 296-305.
5. Futch T, Spinosa J, Bhatt S, et al. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013; 33:569-74.
6. Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11, 105 pregnancies with mixed risk factors. Prenat Diagn 2012; 32:1225-32.
7. Chetty S, Garabedian MJ, Norton ME. Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 2013; 33:542-6.
8. Ohno M, Caughey A. The role of noninvasive prenatal testing as a diagnostic versus a screening tool-a cost-effectiveness analysis. Prenat Diagn 2013; 33:630-5.
9. Manegold-Brauer G, Berg C, Flock A, et al. Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center. Arch Gynecol Obstet 2015; 292:543-8.
10. Williams J3rd, Rad S, Beauchamp S, et al. Utilization of noninvasive prenatal testing: Impact on referrals for diagnostic testing. Am J Obstet Gynecol 2015; 213:102.e1-6.
11. Friel LA, Czerwinski JL, Singletary CN. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine. Am J Perinatol 2014; 31:759-64.
12. Manegold-Brauer G, Kang Bellin A, Hahn S, et al. A new era in prenatal care: non-invasive prenatal testing in Switzerland. Swiss Med Wkly 2014; 144:w13915.
13. Platt LD, Janicki MB, Prosen T, et al. Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States. Am J Obstet Gynecol 2014; 211:e361-7.
14. Wellesley D, Dolk H, Boyd PA, et al. Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe. Eur J Hum Genet 2012; 20: 521-6.
15. Kagan KO, Avgidou K, Molina FS, et al. Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstet Gynecol 2006; 107:6-10.
16. Committee Opinion No. 640Cell-free DNA screening for fetal aneuploidy. Obstet Gynecol 2015; 126:e31-7.
17. Dhaifalah I, Dusek L, Santavy J. Implementation of One-Stop-Clinic for Risk Assessment of chromosomal abnormalities in the first trimester, evaluating the effectiveness and making it part of our daily practice. Ceska gynekologie /Ceska lekarska spolecnost. J Ev Purkyne 2011; 76: 292-306.
18. Zhou Q, Pan L, Chen S, et al. Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: A hospital experience. Prenat Diagn 2014; 34:1061-5.
19. Ke WL, Zhao WH, Wang XY. Detection of fetal cell-free DNA in maternal plasma for Down syndrome, Edward syndrome and Patau syndrome of high risk fetus. Int J Clin Exp Med 2015; 8:9525-30.
20. Mennuti MT, Cherry AM, Morrissette JJ, et al. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy? Am J Obstet Gynecol 2013; 209:415-9.
21. Wang JC, Sahoo T, Schonberg S, et al. Discordant noninvasive prenatal testing and cytogenetic results: A study of 109 consecutive cases. Genet Med 2015; 17:234-6.
22. Benn P, Cuckle H, Pergament E. Non-invasive prenatal testing for aneuploidy: Current status and future prospects. Ultrasound Obstet Gynecol 2013; 42:15-33.
23. Cuckle H, Benn P, Pergament E. Maternal cfDNA screening for Down syndrome-a cost sensitivity analysis. Prenat Diagn 2013; 33:636-42.
24. Gil MM, Akolekar R, Quezada MS, et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: Meta-analysis. Fetal Diagn Ther 2014; 35:156-73.
25. Committee Opinion No. 545Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012; 120:1532-4.
26. Bianchi DW, Rava RP, Sehnert AJ. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014; 371:578.
27. Lau TK, Cheung SW, Lo PS, et al. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: Review of 1982 consecutive cases in a single center. Ultrasound Obstet Gynecol 2014; 43:254-64.
28. Liao C, Yin AH, Peng CF, et al. Noninvasive prenatal diagnosis of common aneuploidies by semiconductor sequencing. Proc Natl Acad Sci USA 2014; 111:7415-20.
29. Tan TY. Combined first trimester screen or noninvasive prenatal testing or both. Singapore Med J 2015; 56:1-3.
30. Rao R, Platt LD. Ultrasound screening: Status of markers and efficacy of screening for structural abnormalities. Semin Perinatol 2016; 40:67-78.
31. Reddy UM, Abuhamad AZ, Levine D, et al. Fetal imaging: Executive summary of a Joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop. Am J Obstet Gynecol 2014; 210: 387-97.
32. ACOG Practice Bulletin No. 77Screening for fetal chromosomal abnormalities. Obstet Gynecol 2007; 109:217-27.
33. Latendresse G, Deneris A. An update on current prenatal testing options: First trimester and noninvasive prenatal testing. J Midwifery Womens Health 2015; 60:24-36.
34. Allyse MA, Sayres LC, Havard M, et al. Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing. Prenatal Diagn 2013; 33:656-61.